Drugs / SSGJ-716
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07693738 | May 2026 → Aug 2027 expected | — | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SSGJ-716 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07693738 ↗ |
| Route | Subcutaneous | “Single and multiple subcutaneous injection” NCT07693738 ↗ |